CEO received an award of 375 BMRN shares | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Apr 30, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Dec 2, 2025
CEOGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001628280-25-054856
- Filed / recorded
Dec 2, 2025, 11:29 PM UTCAdded to OQROOct 6, 2026, 4:40 PM UTC Data qualityVerified: identifiers matched exactly IssuerBIOMARIN PHARMACEUTICAL INC Reporting personAlexander Hardy RelationshipDirector, Officer Officer titleChief Executive Officer TableNon-derivative (Table I) Transaction dateApr 30, 2025 Acquired / disposedAcquired (A) Shares owned after175,958 Footnotes from the filing
- Represents the shares acquired by the reporting person on April 30, 2025, pursuant to the issuer's Employee Stock Purchase Plan.
Around the same time
Traded Dec 1, 2025 · filed 1 day later
Routine share withholding; mechanical by default.